Gadolinium-based contrast agents (GBCAs) are used in MRI to enhance the visibility of internal structures, but they carry a risk of nephrogenic systemic fibrosis in patients with impaired kidney function. Recent developments focus on reducing gadolinium retention in the body to improve patient safety.

Gadolinium-based Contrast Agents

GBCAs

Magnetic Resonance Imaging (MRI) is a non-invasive diagnostic technique that uses powerful magnets and radio waves to generate detailed images of the body's internal structures, particularly soft tissues. It is widely used in medical settings for diagnosing conditions, monitoring treatment progress, and guiding surgical planning without exposing patients to ionizing radiation.

Internal structures

Nephrogenic Systemic Fibrosis

Impaired Kidney Function

Gadolinium Retention

Patient safety is a fundamental principle of healthcare that aims to prevent harm to patients during the provision of health services. It involves the establishment of systems and processes to minimize errors and adverse events, ensuring high-quality and reliable care.

Concepts

Your Lessons